Manufacturer record
Vision Parentral Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Vision Parentral Pvt. Ltd was declared Not of Standard Quality in August 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MP24040508 5, Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection) RL 500ml (exp Mar 2027). CDL Kolkata (CDSCO lab) found it not of standard quality: Sterility. Listed in the August 2024 alert.
Records by type
1 record linked to Vision Parentral Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection) RL 500ml | Batch MP24040508 5Mfg Apr 2024 · Exp Mar 2027 | SterilitySterility | CDL KolkataCDSCO lab | Aug 2024 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP | 825D167 | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | May 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.